Trials / Unknown
UnknownNCT03100682
Prevention of Human Papillomavirus (HPV) Infection in Paediatric Kidney and Liver Transplant Recipients and in Paediatric Patients With Advanced Chronic Kidney Disease
Prevention of Human Papillomavirus (HPV) Infection in Paediatric Kidney and Liver Transplant Recipients and in Paediatric Patients With Advanced Chronic Kidney Disease: a Prospective, Observational Multi-centre Vaccine Surveillance Study (HPVaxResponse Study)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 140 (estimated)
- Sponsor
- University Hospital Heidelberg · Academic / Other
- Sex
- All
- Age
- 9 Years
- Healthy volunteers
- Not accepted
Summary
Due to their immunosuppressive therapy, solid-organ transplant (SOT) recipients bear a 10 to 100 times higher risk of human papillomavirus (HPV)-associated malignancies than healthy individuals. The objectives of this observational, non-interventional multi-national, multi-centre research project are to gain an insight into current HPV vaccination strategies and to investigate the immune response to different routinely administered HPV vaccines in European paediatric SOT candidates and immunocompromised transplant recipients, enabling patients at risk of vaccination failure to be identified.
Conditions
Timeline
- Start date
- 2017-03-18
- Primary completion
- 2022-03-01
- Completion
- 2022-12-01
- First posted
- 2017-04-04
- Last updated
- 2021-06-02
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03100682. Inclusion in this directory is not an endorsement.